PL376052A1 - Peptydy terapeutyczne - Google Patents
Peptydy terapeutyczneInfo
- Publication number
- PL376052A1 PL376052A1 PL03376052A PL37605203A PL376052A1 PL 376052 A1 PL376052 A1 PL 376052A1 PL 03376052 A PL03376052 A PL 03376052A PL 37605203 A PL37605203 A PL 37605203A PL 376052 A1 PL376052 A1 PL 376052A1
- Authority
- PL
- Poland
- Prior art keywords
- ligand
- provides
- therapeutic peptides
- product
- sulphonation
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 239000003446 ligand Substances 0.000 abstract 3
- 102000005962 receptors Human genes 0.000 abstract 2
- 108020003175 receptors Proteins 0.000 abstract 2
- 241000588655 Moraxella catarrhalis Species 0.000 abstract 1
- 101710116435 Outer membrane protein Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000013595 glycosylation Effects 0.000 abstract 1
- 238000006206 glycosylation reaction Methods 0.000 abstract 1
- 230000033444 hydroxylation Effects 0.000 abstract 1
- 238000005805 hydroxylation reaction Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
- C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0222764.3A GB0222764D0 (en) | 2002-10-02 | 2002-10-02 | Therapeutic peptide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL376052A1 true PL376052A1 (pl) | 2005-12-12 |
Family
ID=9945111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL03376052A PL376052A1 (pl) | 2002-10-02 | 2003-10-01 | Peptydy terapeutyczne |
Country Status (17)
| Country | Link |
|---|---|
| EP (2) | EP1546194B1 (pl) |
| JP (1) | JP4763291B2 (pl) |
| KR (1) | KR101057587B1 (pl) |
| CN (1) | CN1305899C (pl) |
| AT (1) | ATE549348T1 (pl) |
| AU (1) | AU2003299131B2 (pl) |
| BR (1) | BR0315031A (pl) |
| CA (1) | CA2500960A1 (pl) |
| ES (1) | ES2383958T3 (pl) |
| GB (1) | GB0222764D0 (pl) |
| IL (1) | IL167780A (pl) |
| MX (1) | MXPA05003474A (pl) |
| NO (1) | NO20052108L (pl) |
| NZ (1) | NZ539575A (pl) |
| PL (1) | PL376052A1 (pl) |
| WO (1) | WO2004031236A2 (pl) |
| ZA (1) | ZA200503446B (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0509936A (pt) * | 2004-04-15 | 2007-09-25 | Univ Bristol | peptìdios terapêuticos |
| WO2007018463A2 (en) * | 2005-08-10 | 2007-02-15 | Arne Forsgren Ab | Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system |
| TW201302779A (zh) | 2011-04-13 | 2013-01-16 | Glaxosmithkline Biolog Sa | 融合蛋白質及組合疫苗 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69740108D1 (de) * | 1996-12-20 | 2011-03-10 | Univ Texas | Moraxella catarrhalis antigene uspa1 und uspa2 |
-
2002
- 2002-10-02 GB GBGB0222764.3A patent/GB0222764D0/en not_active Ceased
-
2003
- 2003-10-01 KR KR1020057005764A patent/KR101057587B1/ko not_active Expired - Fee Related
- 2003-10-01 MX MXPA05003474A patent/MXPA05003474A/es active IP Right Grant
- 2003-10-01 ES ES03756554T patent/ES2383958T3/es not_active Expired - Lifetime
- 2003-10-01 NZ NZ539575A patent/NZ539575A/en not_active IP Right Cessation
- 2003-10-01 EP EP03756554A patent/EP1546194B1/en not_active Expired - Lifetime
- 2003-10-01 AU AU2003299131A patent/AU2003299131B2/en not_active Ceased
- 2003-10-01 AT AT03756554T patent/ATE549348T1/de active
- 2003-10-01 BR BR0315031-3A patent/BR0315031A/pt not_active IP Right Cessation
- 2003-10-01 WO PCT/GB2003/004273 patent/WO2004031236A2/en not_active Ceased
- 2003-10-01 PL PL03376052A patent/PL376052A1/pl not_active IP Right Cessation
- 2003-10-01 JP JP2004540969A patent/JP4763291B2/ja not_active Expired - Fee Related
- 2003-10-01 CA CA002500960A patent/CA2500960A1/en not_active Abandoned
- 2003-10-01 EP EP10177682A patent/EP2305700A1/en not_active Withdrawn
- 2003-10-01 CN CNB2003801017669A patent/CN1305899C/zh not_active Expired - Fee Related
-
2005
- 2005-03-31 IL IL167780A patent/IL167780A/en not_active IP Right Cessation
- 2005-04-29 NO NO20052108A patent/NO20052108L/no not_active Application Discontinuation
- 2005-04-29 ZA ZA200503446A patent/ZA200503446B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006516952A (ja) | 2006-07-13 |
| GB0222764D0 (en) | 2002-11-06 |
| AU2003299131A1 (en) | 2004-04-23 |
| IL167780A (en) | 2011-05-31 |
| EP1546194A2 (en) | 2005-06-29 |
| BR0315031A (pt) | 2005-08-16 |
| NZ539575A (en) | 2006-06-30 |
| KR101057587B1 (ko) | 2011-08-19 |
| CN1305899C (zh) | 2007-03-21 |
| CA2500960A1 (en) | 2004-04-15 |
| WO2004031236A2 (en) | 2004-04-15 |
| NO20052108D0 (no) | 2005-04-29 |
| CN1705678A (zh) | 2005-12-07 |
| EP2305700A1 (en) | 2011-04-06 |
| MXPA05003474A (es) | 2005-10-18 |
| HK1076475A1 (en) | 2006-01-20 |
| KR20050067410A (ko) | 2005-07-01 |
| ZA200503446B (en) | 2006-10-25 |
| NO20052108L (no) | 2005-06-27 |
| WO2004031236A3 (en) | 2004-06-24 |
| ATE549348T1 (de) | 2012-03-15 |
| EP1546194B1 (en) | 2012-03-14 |
| AU2003299131B2 (en) | 2010-04-22 |
| JP4763291B2 (ja) | 2011-08-31 |
| ES2383958T3 (es) | 2012-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2432364C2 (ru) | ПОЛИКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВ Nogo, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И ПРИМЕНЕНИЕ АНТИТЕЛА ДЛЯ ИЗГОТОВЛЕНИЯ ЛЕКАРСТВЕННОГО СРЕДСТВА | |
| AU2003270643A8 (en) | Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence | |
| NL300830I2 (nl) | Protein Q, een recombinant chimeer eiwit, bestaande uit vijf antigenefragmenten van vier verschillende Leishmania infantum (zymodeme Mon-1) eiwitten | |
| PL392964A1 (pl) | Antygen reaktywny wobec surowicy hiperimmunologicznej zastosowanie tego antygenu do produkcji preparatu farmaceutycznego, fragment hiperimmunologiczny antygenu, epitopy pomocnicze antygenu, szczepionka zawierająca antygen reaktywny wobec surowicy hiperimmunologicznej, preparat zawierający przeciwciała, sposób wytwarzania tego preparatu, zastosowanie preparatu do leczenia infekcji gronkowcowych oraz sposób przesiewania | |
| DE69638022D1 (de) | Aus wirbeltieren und darauf basierende verfahren | |
| GR3034349T3 (en) | Neutralizing monoclonal antibodies to respiratory syncytial virus | |
| IS6455A (is) | Stöðvun á vexti taugasíma fyrir milligöngu viðtaka Nogo | |
| EP1539228A4 (en) | NEW COMPOSITION AND METHOD FOR THE TREATMENT OF IMMUNE DISEASES | |
| SE0103754L (sv) | Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid | |
| DE68925226D1 (de) | Monoklonale Antikörper | |
| CN101405298A (zh) | 垂体腺苷酸环化酶激活肽(pacap)受体(vpac2)激动剂及其药物使用方法 | |
| DE69831500D1 (de) | Humane checkpointkinase, hcds1, zusammensetzungen und verfahren | |
| DK0494294T3 (da) | Bakterielle stressproteiner | |
| PT996726E (pt) | Proteina de membrana de celulas t (tirc7) peptidos e anticorpos dela derivados e suas utilizacoes | |
| WO2005099337A3 (en) | Therapeutic peptides | |
| GB0222764D0 (en) | Therapeutic peptide | |
| Rajnavölgyi et al. | Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites | |
| AU2003279352B2 (en) | DNA sequence and recombinant production of the grass pollen allergen Phl p4 | |
| EP1467207A4 (en) | Screening method | |
| WO2003064446A3 (en) | Plasma protein-binding peptides from bacterial curli | |
| Khaddah et al. | Assessment of preclinical efficacy antivenoms produced in rabbit by immunological methods and neutralization assays | |
| MY106163A (en) | Bcrf1 antagonists for treating epstein-barr virus infections. | |
| WO2007042326A3 (en) | Neisseria meningitidis antigens | |
| HK1027837A (en) | Diagnosis and treatment of diseases using anti-t-cell receptor vbeta antibodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein 1 (esrp1) | |
| WO2004005331A3 (en) | Peptides derived from pep133 (g1p3, 6-16) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| VOID | Decisions declaring the decisions on the grant of the patent lapsed |